Abstract: Fibromyalgia syndrome (FMS) is a chronic disorder characterized by widespread and persistent musculoskeletal pain and other frequent symptoms such as fatigue, insomnia, morning stiffness, cognitive impairment, depression, and anxiety. FMS is also accompanied by different comorbidities like irritable bowel syndrome and chronic fatigue syndrome. Although some factors like negative events, stressful environments, or physical/emotional traumas may act as predisposing conditions, the etiology of FMS remains unknown. There is evidence of a high prevalence of psychiatric comorbidities in FMS (especially depression, anxiety, borderline personality, obsessive-compulsive personality, and post-traumatic stress disorder), which are associated with a worse clinical profile. There is also evidence of high levels of negative affect, neuroticism, perfectionism, stress, anger, and alexithymia in FMS patients. High harm avoidance together with high self-transcendence, low cooperativeness, and low self-directedness have been reported as temperament and character features in FMS patients, respectively. Additionally, FMS patients tend to have a negative self-image and body image perception, as well as low selfesteem and perceived self-efficacy. FMS reduces functioning in physical, psychological, and social spheres, and also has a negative impact on cognitive performance, personal relationships (including sexuality and parenting), work, and activities of daily life. In some cases, FMS patients show suicidal ideation, suicide attempts, and consummated suicide. FMS patients perceive the illness as a stigmatized and invisible disorder, and this negative perception hinders their ability to adapt to the disease. Psychological interventions may constitute a beneficial complement to pharmacological treatments in order to improve clinical symptoms and reduce the impact of FMS on health-related quality of life.
Introduction
Fibromyalgia syndrome (FMS) is a chronic disorder characterized by widespread and persistent musculoskeletal pain that predominantly affects women (between 61% and 90%) 1 and has an estimated prevalence of 2%-4% in the general population. 2 Other associated symptoms are fatigue, insomnia, morning stiffness, depression, and anxiety.
FMS is frequently accompanied by other conditions such as irritable bowel syndrome, headache, fever, diarrhea, oral ulcers, dry eyes, vomit, constipation, skin rash, hearing difficulties, hair loss, painful and frequent urination, etc.
2 FMS is associated with high socioeconomic costs for the health system (medical visits, specialized consultations, diagnostic tests, drugs, and others therapies) and the workforce (sick FMS was recognized as an illness by the WHO in 1992, being included in the ICD-10 under code number M79. 5 The etiology of FMS remains unknown. Current pathophysiological models assume a central sensitization to pain and impairments in endogenous pain inhibitory mechanisms 4, [6] [7] [8] ( Figure  1 ). This idea is supported by the existence of hyperalgesia and allodynia, low thresholds and tolerance to pain, development of pain sensitization in the dorsal horns of the spinal cord in response to repeated pain, and greater brain responses to pain evocation observed in areas of the pain neuromatrix. [6] [7] [8] 10, 11 However, other authors have considered neurological origin of FMS, based on the discovery of small fiber 12, 13 and large fiber 14 neuropathy in the affected patients. 12 Moreover, the involvement of idiopathic cerebrospinal pressure dysregulation in FMS pathology is discussed. 15 In 1990, the American Colleague of Rheumatology (ACR) established the first diagnostic criteria for FMS, wherein pain pressure up to 4 kg/cm 2 was evaluated at 18 body points; pain elicited in at least eleven of them was required for a diagnosis. 16 However, these criteria were widely criticized due to the difficulties in using pressure algometry in primary health care and the limited predictive validity with respect to clinical pain. 17 Thus, in 2010, a new proposal was presented by the ACR exclusively based on the use of two scales: the Widespread Pain Index (WPI) and the Severity Scale (SS). The WPI includes a list of 19 painful areas and the SS involves an evaluation of the severity of certain clinical symptoms. For an FMS diagnosis, a WPI score ≥7 and SS score ≥5 or a WPI score between 3 and 6 and SS score ≥9 is needed. As with 1990 criteria, the symptoms must be present continuously over the period of at least 3 months. 2 
Vulnerability factors in fibromyalgia
Some factors seem to predispose individuals to FMS, such as accidents (traffic and work injuries, fractures, polytraumatisms), medical interventions and complications (such as from surgeries and infections), and emotional traumas (sexual and physical abuse and neglect). [18] [19] [20] Environmental factors like stressful life events may be associated with FMS onset. 21, 22 FMS patients who report sexual or physical abuse tend to experience poorer psychological adjustment, greater psychological distress, and more severe clinical symptoms, and use more health care services. [23] [24] [25] In general, studies have found an association between traumas during childhood and adolescence (not only abuse or violence, but also negligence and other negative life events) and level of disability in FMS. 26 Dysregulation of stress response mechanisms may antecede the development of FMS and other chronic conditions like chronic fatigue syndrome. Early stress in human development could alter stress mechanisms, leading to increased vulnerability to stress-related disorders. As such, lengthy trauma or life stress in childhood and adulthood seems to negatively affect brain modulatory systems, of both pain and emotions. 27 Though life experiences may partially explain the high prevalence of emotional disorders and alterations in pain modulation in FMS, the corresponding state of research does not allow definite conclusions. 
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Galvez-Sánchez et al FMS patients show blunted HPA (hypothalamuspituitary-adrenal) reactivity (particularly at the pituitary level), which leads to an inappropriate cortisol response to stress or activities of daily living. 28, 29 FMS patients also displayed aberrant autonomic regulation 17 with lower activity of both the sympathetic and parasympathetic branches (such as higher heart rate and lower heart rate variability, blood pressure, stroke volume, etc) and reduced reactivity to physical and psychological stressors. 30, 31 This leads to a reduced capacity to face and cope successfully with environmental and daily life demands. Furthermore, the activity of the baroreflex, the main mechanism mediating the antinociceptive effect of blood pressure, is decreased. 26, 27 Moreover, the negative effect of negative life events seems to be enhanced and maintained due to the patients' tendency toward catastrophizing, 10 avoidance, or inhibition of their emotions. 32 Physical inactivity and sedentary lifestyles, and the associated increase in body mass index (BMI), have been suggested as factors associated with FMS. 33, 34 Activity avoidance is associated with poorer function in individuals with chronic pain, and predicted poorer physical and psychological functioning and higher pain-related interference with daily life. 35 Overactive patterns can also contribute in the long term to increased risk of pain exacerbation, and patients with an overactive coping style when engaging in daily life activities usually report poorer physical and psychological function. 35 In contrast, patients who pace themselves (such as by slowing down and taking breaks to facilitate goal attainment) in their daily activities report lower pain interference and greater psychological function and pain control. 35 Family aggregation in FMS, suggesting genetic influences, has been observed. [36] [37] [38] There is a greater prevalence of mood disorders (especially major depressive and bipolar disorders) and reduced pressure pain thresholds in the relatives of FMS patients. However, the specific genes and mechanisms of transmission are unknown, although they are probably polygenic, for instance, HLA antigen class I and II, DR4, 5-HTT, 5-HTTLPR, D2 receptor, catechol-Omethyltransferase polymorphism, etc. 36, 37 In spite of the evidence regarding the abovementioned predisposing factors (which cannot be considered causal), more research is needed to comprehensively understand their contribution to FMS origin and maintenance.
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Impact on health-related quality of life FMS negatively affects functioning at the physical, psychological, and social levels, impairing social relationships, ability to fulfill family and work responsibilities, daily life activities, and mental health, not only due to pain but also because of fatigue, cognitive deficits, and other associated symptoms. [40] [41] [42] The quality of life of relatives can also be affected. Work is especially affected due to the tension between health problems (pain, fatigue, muscle weakness, limited physical capacity, increased stress, and increased need of rest) and work-related demands. 43, 44 It is important to provide familial and general social support to FMS workers, taking into account the fact that working patients show better health status and adaptation than non-working patients. 45, 46 FMS patients should have the opportunity to adjust their work situation and workload according to their reduced physical capacity for fulltime work, or decide definitively if they can or cannot work. 47, 48 In this vein, the WHO recommends workplace adjustments for health reasons. 49 FMS negatively affects sexual health 50 and is related to reproduction problems 51 and female sexual dysfunctions, 52, 53 such as hypoactive sexual desire, 54 sexual aversion, orgasm disorder, vaginismus, and dyspareunia. 55 Characteristic FMS symptoms (particularly widespread pain, fatigue, sleep disorders, and hypersensitivity and intolerability to tactile and pressure stimuli) 56 together with psychiatric comorbidities 57 (especially anxiety and depression), 58, 59 body image problems, 60 decreased lubrication, 61 pelvic floor muscle problems, 62 and medication side effects, 63 are some of the main causes of sexual problems (Table 1) . With a multidisciplinary approach, it is necessary to treat sexual problems in FMS, as they are not only a cause of discomfort, which worsens symptoms and quality of life, but also lead to interpersonal problems and the breakup of couples. 64 
Cognitive impact of fibromyalgia
Lower cognitive performance has been found in FMS patients compared to healthy people. 33, 65, 66 FMS patients usually report cognitive impairments, especially problems in planning, attention, memory (in the working, semantic, and episodic domains), executive functions, and processing speed. 33, 67, 68 These findings accord with self-reported cognitive deficits, which usually include concentration difficulties, forgetfulness, decreased vocabulary, poor verbal fluency, and mental slowness. 69, 70 Nevertheless, the cognitive deficit does not seem to be global. 71 Additionally, higher levels of fatigue have been found during cognitive tasks in FMS patients compared to healthy people. 72 The main mediating factor of these cognitive deficits is the severity of clinical pain. [73] [74] [75] 
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Galvez-Sánchez et al depression, and negative emotional states), 76, 77 fatigue, and insomnia. [78] [79] [80] Emotional and affective impact of fibromyalgia FMS is linked to greater negative affect, [74] [75] [76] which involves a general state of distress composed of aversive emotions like sadness, fear, anger, and guilt. 77 In addition, FMS patients tend to experience high levels of stress, 78, 79 anger (including anger-in or anger suppression, anger-out or anger expression, and angry rumination), [80] [81] [82] and pain catastrophizing (conceptualized as an exaggerated negative orientation to pain, which provokes fear and discomfort and increases pain perception), 83 which are frequently associated with a worsening of symptoms, 84 including cognitive ones. 66 Psychiatric disorders can accompany rheumatic diseases and may increase disability and mortality, as well as reduce quality of life in these patients. 85, 86 FMS patients display a high rate of anxiety (20%-80%) 87 and depressive disorders (13%-63.8%). 88 Specifically, a higher prevalence in FMS patients than in the general population was observed for generalized anxiety disorder, panic attack, phobias, 89 obsessive compulsive disorder, 90 post-traumatic stress disorder, 90,91 major depressive disorder, 92 dysthymia, 93 and bipolar disorders.
94,95
The intensity of negative affective states is positively associated with increased pain intensity, irritability, physical and mental strain, functional limitations, the number of tender points, non-restorative sleep, cognitive deficits, fatigue, and the impact of the illness on quality of life. 90, 96, 97 FMS patients usually feel isolated, misunderstood, or rejected by relatives, friends, health workers, and society in general. This may contribute to the high prevalence of depression, along with the constant and intense pain. 90 There is also evidence of high levels of anxiety related to FMS patients' heightened perception of pain and somatization of symptoms. 88 Chronic pain is a risk factor for suicidal behaviors. 98 In the case of FMS, the estimated prevalence of suicidal attempts has been reported as 16.7%, 99 rising to 58.3% in the case of FMS with comorbid migraine. 100 Thus, FMS patients have a higher rate of suicide attempts than the general population, where their risk of suicide is similar to that observed in other chronic diseases. 101 Suicidal behaviors in FMS include suicidal ideation, 102, 103 suicide attempts, 104 and death by suicide. 105, 106 The risk of suicide in FMS is increased due to the presence of a constellation of factors that are usually related to suicide, such as being female, 107 psychological distress, poor sleep quality, 108, 109 enhanced fatigue, 110 psychiatric comorbidities (especially depression, bipolar disorders, and borderline personality), 101, 108, 111 and physical comorbidities (like headache and gastric diseases). 101 Suicidal ideation is more common than suicide attempts 112 and the latter occurs ten times more frequently than suicide. 113 Suicidal ideation 
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Galvez-Sánchez et al in FMS is related to comorbid depression, anxiety, and a high negative impact on daily life activities. 103 The inclusion of FMS patients in suicide risk assessments in clinical practice, to prevent suicide, is an important consideration in clinical practice.
Personality, temperament, character, and fibromyalgia
Personality characteristics modulate an individual's response to psychological stressors 27 and adjustment to chronic illness. 27 An "FMS personality" is a topic that remains under debate. While some authors have found characteristic FMS traits, 27 others have failed to find any particular personality features. 114 Some personality disorders appear to be more prevalent in FMS patients than in the general population, including obsessive-compulsive personality disorder, 115, 116 borderline personality, 94 avoidant personality disorder, 117, 118 and histrionic personality disorder. 115 Some studies have observed a predominance of certain personality traits in FMS, such as perfectionism, 119, 120 alexithymia, 84, 121 neuroticism, 27, 122, 123 psychocitism, 123 avoidant personality traits, 115, 117, 118 and type D personality 124 (which combine high negative affect with social inhibition). 125 Some studies have focused on the Big Five Model of Personality, which includes five dimensions: extraversion vs introversion, agreeableness vs antagonism, conscientiousness vs impulsivity, neuroticism vs emotional stability, and openness vs closed-mindedness. 126 In FMS, high neuroticism and low conscientiousness (high impulsivity) have been found, which seem to be related to high levels of chronic pain. 126 Furthermore, in some FMS patients, the high level of neuroticism is usually accompanied by low extraversion, contributing to more severe psychosocial problems. 127 Extraversion in FMS is associated with lower levels of pain, anxiety, and depression, and better mental health, thereby constituting a protective influence against FMS. 45 In general, the presence of personality disorders and negative personality traits in FMS is associated with poorer results after pain treatment, 128, 129 a worsening of the functional status, higher health care demands (particularly in terms of increased number of medical visits), and greater occupational and medical costs. 118, 130 Some studies have focused on the temperament and character of FMS patients, mainly based on Cloninger's Personality Model, using the Temperament and Character Inventory. 131 High harm avoidance, high self-transcendence, low cooperativeness, and self-directedness have been found in FMS patients. [132] [133] [134] Harm avoidance is related to pessimism, concerns about the future, fear of the unknown, and shyness. Self-transcendence can be conceptualized as spiritual ideas that involve a state of unified consciousness in which everything is an integral part of a totality, favoring a spiritual union with the universe. Self-transcendence has been associated with post-traumatic stress and psychotic symptoms, such as borderline, narcissistic, schizotypal, and paranoid symptoms. 135 Low levels of cooperativeness include social intolerance, lack of social interest, and a tendency to further their own interests. People with low self-directedness usually have difficulties in accepting responsibility and being independent, and show a lack of long-term goals, low motivation, and low self-esteem. 131 
Impact of FMS on self-concept
The few studies available in this field have found lower selfesteem 66, 136, 137 levels in FMS patients. Lower self-esteem is related to a reduction of cognitive performance in FMS, especially in terms of attention, memory, and planning abilities. 66 FMS patients tend to experience a higher need to earn selfesteem through competence and others' approval. It is known that self-esteem is related to self-confidence and self-efficacy expectations. 136, 137 Self-efficacy (the confidence one has in one's ability to perform or resolve a specific behavior or problem) 138 or perceived self-efficacy (individuals' beliefs in their capacities to achieve certain goals) 139 is usually low in FMS patients. 140, 141 Pain-related self-efficacy, conceptualized as beliefs about the ability to perform activities despite pain, 142 is also damaged in FMS. 140, 143 A high positive association has been found between self-efficacy and treatment adherence and improvements in FMS, with better self-efficacy being associated with more positive outcomes. 140, 141 Thus, interventions aimed at increasing self-esteem may be useful to improve expectations of self-efficacy and the patient's own ability to manage their illness, thus promoting better adaptation to the disease. 144 Several studies have shown a precarious or negative self-image in FMS patients. 116, 145 Self-image problems are associated with the notion of an ill person, which radically alters FMS patients' self-identity. Moreover, FMS patients' self-image seems to be modified during the development and course of the illness 146 and therapeutic interventions, 147 affecting their self-identity. 148 In spite of the relevance of the self-image concept, few studies to date have addressed this issue.
Body image is part of the overall self-image and is defined as the subjective perceptions, feelings, and thoughts about the physical body. It includes perceptual and affective compo- 
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Galvez-Sánchez et al nents, 149 which are usually affected in pain-related illnesses. 150 Indeed, there is evidence of a negative body image in FMS patients, 151, 152 further exacerbated by the high prevalence of overweight and obesity. 153, 154 FMS body image also seems to be influenced by the illness-affected body parts (especially painful and stiff areas), problems in cognitive function, negative health care experiences, activity limitations, and decreased quality of life.
151

Patient beliefs about fibromyalgia
The unknown etiology of FMS and the lack of objective diagnostic markers of the disease have led to a debate about its legitimacy and controversies regarding its true nature. 114 The negative experience of FMS patients is exacerbated due to the occasional perception that it is not a genuine disease. 155 Additionally, FMS patients cite the lack of physical markers of the illness as a reason for the delay in diagnosis and the source of doubts about the authenticity of the illness. 151 Many FMS patients report that their family and friends do not understand their disease; [156] [157] [158] this lack of support could affect their functioning and recovery. Some studies have confirmed the relevance of support from family, friends, and health care staff for managing daily life with chronic illnesses, including FMS. 159, 160 In this way, FMS patients feel a double burden because their life is dominated by pain but it is not adequately acknowledged. 161 In fact, the process of FMS diagnosis is stressful for patients due to the lack of objective clinical markers and physician doubts, together with the general uncertainty of the process. 162 The majority of FMS patients feel relieved when they finally receive their FMS diagnosis. However, this relief tends to evaporate when they realize the ineffectiveness of treatments and the illness prognosis. 163, 164 Patients with FMS experience a sense of invisibility because of debates regarding the authenticity of the diagnosis, treatment, and health care in general. 155, 165 Moreover, FMS patients usually feel embarrassed because they are no longer able to perform daily tasks as before. 156 In fact, they have problems in planning daily life activities and interactions with family and their social circles due to the severity of their symptoms, such that they become more isolated. 157, 161, 166 Dissatisfaction with the patient-doctor relationship is another recurring problem, together with frustration due to uncertainty regarding the etiology and treatment of FMS. 164 FMS seems to undermine patients' self-confidence and sense of self 155 and disrupts their identity. 167 In this sense, FMS patients experience a transition or change in identity due to the illness, which is apparently invisible to the people who saw them when healthy due on the basis of their external or physical appearance. 168 Clearly, FMS patients can be perceived negatively, which worsens their symptoms and functioning. In their own words, they experience "illness intrusiveness" characterized as disruptions of valued activities, lifestyle, and interests, leading to compromised global quality of life. Evidence also suggests that feelings of vulnerability and apprehension about having a chronic illness of unknown origin may contribute to limiting patients' activities, inability to sustain work, and somatic distress.
169,170
Conclusion
FMS is associated with a high prevalence of emotional and affective disorders (particularly depression, anxiety, borderline personality, obsessive-compulsive personality, and post-traumatic stress disorder), and main symptoms and comorbidities may mutually reinforce each other. FMS reduces functioning in the physical, psychological, and social spheres, and has a negative impact on personal relationships (including sexuality and parenting), work, daily activities, and mental health. FMS patients also show problems in cognitive performance, especially in planning, attention, memory, executive functions, and processing speed. There is also evidence of high levels of negative affect, neuroticism, perfectionism, stress, anger, and alexithymia in FMS patients. High harm avoidance together with high self-transcendence, low cooperativeness, and low self-directedness have been found as temperament and character features of FMS patients. Furthermore, FMS patients tend to have a negative self-image and body image perception, as well as low self-esteem and perceived self-efficacy. In some cases, FMS patients show suicidal ideation, suicide attempts, and consummated suicide. FMS patients perceived the illness as a stigmatized and invisible disorder that is difficult to understand. The negative illness perception and lack of social support worsen their symptoms and functioning.
Due to the scarce etiological knowledge about FMS, there is currently no agreement about its appropriate therapy, and treatment effects have been claimed to be unsatisfactory. 171 However, various interventions, especially combinations of pharmacological with other types of treatments, may be helpful in reducing FMS symptoms and their impact on quality of life. Some evidence is available for positive effects of moderate aerobic exercise, cognitive-behavioral therapy, self-management programs, mindfulness training, and acceptance and commitment therapy. 
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Galvez-Sánchez et al self-esteem, and pain self-efficacy. 173 Finally, FMS patients should stay active at the physical and social levels, and avoid sedentary lifestyles in order to control BMI and improve functioning and health-related quality of life. 174 However, further research is clearly warranted in order to establish a platform from which to develop guidelines regarding psychological interventions in FMS.
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